{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Camarillo",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "70682",
      "recalling_firm": "Fusion Pharmaceuticals, LLC",
      "address_1": "768 Calle Plano Suite A",
      "address_2": "N/A",
      "postal_code": "93012-8555",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "California",
      "recall_number": "D-0410-2015",
      "product_description": "DICOPANOL (diphenhydramine hydrochloride in 5 mg/mL oral suspension kit) FusePaq, 150 mL Kits, Rx Only.  Fusion Pharmaceuticals LLC., 768 Calle Plano, Camarillo, CA 93012. NDC: 43093-104-01.",
      "product_quantity": "9,439 Kits",
      "reason_for_recall": "Microbial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans.",
      "recall_initiation_date": "20150306",
      "center_classification_date": "20150312",
      "termination_date": "20151027",
      "report_date": "20150318",
      "code_info": "Lot Numbers: PL713, PL714, PL715, PL716, PL717, PL718, PL719, PL720, PL721, PL722, PL735, PL736, PL737, PL738, PL739, PL740, PL741, PL742, PL743, PL744; Expiry: 7/20/2015."
    }
  ]
}